Malin Deon | Investor Relations |
Rich Murray | President & Chief Executive Officer |
Elizabeth Trehu | Chief Medical Officer |
Kim Drapkin | Chief Financial Officer |
Boris Peaker | Cowen |
Mike Ulz | Baird |
Steve Seedhouse | Raymond James |
Zegbeh Jallah | ROTH Capital Markets |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference is being recorded at the company's request. I will now turn the call over to your host, Malin Deon with Jounce Therapeutics.